JPH0155244B2 - - Google Patents

Info

Publication number
JPH0155244B2
JPH0155244B2 JP56153513A JP15351381A JPH0155244B2 JP H0155244 B2 JPH0155244 B2 JP H0155244B2 JP 56153513 A JP56153513 A JP 56153513A JP 15351381 A JP15351381 A JP 15351381A JP H0155244 B2 JPH0155244 B2 JP H0155244B2
Authority
JP
Japan
Prior art keywords
amoxicillin
desiccant
composition
tablet
clavulanic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56153513A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5791921A (en
Inventor
Uiriamu Baansutetsudo Barii
Jon Ruuku Debitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10516342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0155244(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of JPS5791921A publication Critical patent/JPS5791921A/ja
Publication of JPH0155244B2 publication Critical patent/JPH0155244B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56153513A 1980-09-27 1981-09-28 Medicine and manufacture Granted JPS5791921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8031298 1980-09-27

Publications (2)

Publication Number Publication Date
JPS5791921A JPS5791921A (en) 1982-06-08
JPH0155244B2 true JPH0155244B2 (OSRAM) 1989-11-22

Family

ID=10516342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56153513A Granted JPS5791921A (en) 1980-09-27 1981-09-28 Medicine and manufacture

Country Status (15)

Country Link
US (1) US4537887A (OSRAM)
EP (1) EP0049061B1 (OSRAM)
JP (1) JPS5791921A (OSRAM)
AU (1) AU549321B2 (OSRAM)
CA (1) CA1187796A (OSRAM)
DE (1) DE3172028D1 (OSRAM)
ES (1) ES8307095A1 (OSRAM)
GB (1) GB2084016B (OSRAM)
GR (1) GR75049B (OSRAM)
HK (1) HK17386A (OSRAM)
IE (1) IE51597B1 (OSRAM)
MY (1) MY8600353A (OSRAM)
NZ (1) NZ198241A (OSRAM)
PT (1) PT73686A (OSRAM)
ZA (1) ZA816272B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS59104319A (ja) * 1982-12-06 1984-06-16 Chugai Pharmaceut Co Ltd 抗菌剤およびそのキツト
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
ATE108996T1 (de) * 1988-02-25 1994-08-15 Brocades Pharma Bv Verfahren zur herstellung eines pharmazeutischen granulats.
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9413542D0 (en) * 1994-07-05 1994-08-24 Smithkline Beecham Plc Pharmaceutical formulations
EP0879772B1 (en) * 1994-08-05 2002-06-12 Smithkline Beecham Plc Pharmaceutical substances in containers and method of dessicating them
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ1926A1 (fr) * 1994-09-03 2002-02-17 Smithkline Beckman P L C Formulations pharmaceutiques.
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
ATE208618T1 (de) * 1995-09-07 2001-11-15 Smithkline Beecham Corp Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
US5801796A (en) * 1996-05-10 1998-09-01 International Business Machines Corporation Stacked parallax-free liquid crystal display cell
GB9617780D0 (en) * 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
KR100499812B1 (ko) * 1997-02-14 2005-07-08 스미스클라인 비참 코포레이션 아목시실린 및 클라불라네이트를 포함하는 약제학적 제형
US6296871B1 (en) * 1998-04-12 2001-10-02 Ranbaxy Laboratories Limited Stable solid pharmaceutical compositions containing enalapril maleate
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
CA2383522C (en) * 1999-08-16 2011-12-06 Revaax Pharmaceuticals, Llc Neurotherapeutic composition and method
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
KR20100101574A (ko) * 2007-10-26 2010-09-17 렉산 파마슈티컬스, 인코포레이티드 클라불란산의 제약 제제
AU2010242948A1 (en) * 2009-04-29 2011-11-24 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
AU2014227598B2 (en) 2013-03-15 2018-12-06 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE888444C (de) * 1951-11-10 1953-08-31 Benckiser Gmbh Joh A Verfahren zum Tablettieren von hygroskopischen Praeparaten
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
GB1209634A (en) * 1967-06-29 1970-10-21 Rit Rech Ind Therapeut Stabilized antibiotic compositions for animal feeding and process for preparing them
DE2512247A1 (de) * 1975-03-20 1976-10-14 Thomae Gmbh Dr K Gegen feuchtigkeit stabilisierte presslinge mit feuchtigkeitsempfindlichen inhaltsstoffen
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions

Also Published As

Publication number Publication date
ES505803A0 (es) 1983-06-16
ES8307095A1 (es) 1983-06-16
CA1187796A (en) 1985-05-28
PT73686A (pt) 1981-10-01
EP0049061A1 (en) 1982-04-07
EP0049061B1 (en) 1985-08-28
NZ198241A (en) 1983-12-16
MY8600353A (en) 1986-12-31
GR75049B (OSRAM) 1984-07-12
GB2084016B (en) 1985-04-17
ZA816272B (en) 1982-09-29
AU549321B2 (en) 1986-01-23
IE51597B1 (en) 1987-01-21
GB2084016A (en) 1982-04-07
AU7568481A (en) 1982-04-08
US4537887A (en) 1985-08-27
DE3172028D1 (en) 1985-10-03
JPS5791921A (en) 1982-06-08
IE812232L (en) 1982-03-27
HK17386A (en) 1986-03-21

Similar Documents

Publication Publication Date Title
JPH0155244B2 (OSRAM)
US4441609A (en) Pharmaceutical compositions
KR100397578B1 (ko) 수분활성을조절한젤라틴캡슐제
HU196708B (en) Process for producing pharmaceutical composition comprising omeprazol and suitable for treating deseases of the digestive system
RS53303A (sr) Farmaceutski sastavi koji sadrže amlodipin maleat
JP2893307B2 (ja) ニコランジルの製薬的に安定な製剤
HU204707B (en) Process for producing peroral pharmaceutical compositions comprising colloidal bismuth subcitrate
BG60901B1 (bg) Гранулат,съдържащ натриев 2-меркаптоетансулфонаткато активно вещество и метод за получаването му
US20070036732A1 (en) Stable topiramate formulations
WO2008132756A1 (en) Stable pharmaceutical compositions of ramipril
JPWO2001089573A1 (ja) 製剤の安定化方法
EP2117534B1 (en) A pharmaceutical composition with atorvastatin active ingredient
US5578321A (en) Controlled release formulation of diltiazem hydrochloride
WO1995005173A1 (en) Oral compositions of h2-antagonists
WO1997017960A1 (en) Pharmaceutical composition comprising amoxycillin and clavulanate and a desiccant
KR810001316B1 (ko) 안정성이 증가된 아목시실린함유 약제조성물의 제조방법
JP2025125515A (ja) アメナメビル含有医薬組成物、並びに、その製造方法及び結晶化抑制方法
JP2025073688A (ja) ボスチニブ医薬製剤
JP2000016931A (ja) 錠剤等の苦味防止方法
WO1996004888A1 (en) Oral compositions of h2-antagonists
WO1996029996A9 (OSRAM)
WO2004028507A1 (en) Method to improve pharmaceutical tablets having a matrix of cellulose ether
CZ12025U1 (cs) Farmaceutické prostředky obsahující amlodipinmaleát a jejich použití